| Dr Dinash Kumar Yanamadula, MD | |
|
123 Franklin Corner Rd, Suite 104, Lawrenceville, NJ 08648-2526 | |
| (386) 316-0850 | |
| Not Available |
| Full Name | Dr Dinash Kumar Yanamadula |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 27 Years |
| Location | 123 Franklin Corner Rd, Lawrenceville, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578507893 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | MA 73395 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital At Hamilton | Hamilton, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Princeton Pain And Spine Institute Pc | 9436394301 | 2 |
News Archive
The Associated Press reports on the larger enrollment in states that are expanding their Medicaid programs. However, The New York Times points out that the snags on the marketplace websites may be holding up thousands of others who will be eligible for the state-federal program for low-income people.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
It's the time of year when many of us celebrate the holidays with festive foods and drinks, including alcohol. No better time then to ask if it is true, as is widely held, that moderate consumption of alcohol is beneficial to health.
Wal-Mart announced this week that it will expand a program that ends out-of-pocket procedure and travel costs for employees seeking some heart and spine surgeries if they go to hospitals across the country that have agreements with the retailer.
› Verified 2 days ago
| Entity Name | Princeton Pain And Spine Institute Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740529080 PECOS PAC ID: 9436394301 Enrollment ID: O20130325000261 |
News Archive
The Associated Press reports on the larger enrollment in states that are expanding their Medicaid programs. However, The New York Times points out that the snags on the marketplace websites may be holding up thousands of others who will be eligible for the state-federal program for low-income people.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
It's the time of year when many of us celebrate the holidays with festive foods and drinks, including alcohol. No better time then to ask if it is true, as is widely held, that moderate consumption of alcohol is beneficial to health.
Wal-Mart announced this week that it will expand a program that ends out-of-pocket procedure and travel costs for employees seeking some heart and spine surgeries if they go to hospitals across the country that have agreements with the retailer.
› Verified 2 days ago
| Entity Name | Riverview Pain And Spine Institute Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972996254 PECOS PAC ID: 2466772538 Enrollment ID: O20150514000148 |
News Archive
The Associated Press reports on the larger enrollment in states that are expanding their Medicaid programs. However, The New York Times points out that the snags on the marketplace websites may be holding up thousands of others who will be eligible for the state-federal program for low-income people.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
It's the time of year when many of us celebrate the holidays with festive foods and drinks, including alcohol. No better time then to ask if it is true, as is widely held, that moderate consumption of alcohol is beneficial to health.
Wal-Mart announced this week that it will expand a program that ends out-of-pocket procedure and travel costs for employees seeking some heart and spine surgeries if they go to hospitals across the country that have agreements with the retailer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dinash Kumar Yanamadula, MD 237 N Bread St, Unit 3, Philadelphia, PA 19106-1238 Ph: (386) 316-0850 | Dr Dinash Kumar Yanamadula, MD 123 Franklin Corner Rd, Suite 104, Lawrenceville, NJ 08648-2526 Ph: (386) 316-0850 |
News Archive
The Associated Press reports on the larger enrollment in states that are expanding their Medicaid programs. However, The New York Times points out that the snags on the marketplace websites may be holding up thousands of others who will be eligible for the state-federal program for low-income people.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
It's the time of year when many of us celebrate the holidays with festive foods and drinks, including alcohol. No better time then to ask if it is true, as is widely held, that moderate consumption of alcohol is beneficial to health.
Wal-Mart announced this week that it will expand a program that ends out-of-pocket procedure and travel costs for employees seeking some heart and spine surgeries if they go to hospitals across the country that have agreements with the retailer.
› Verified 2 days ago